Petrus J. de Vries

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · The Lancet · 2013 · 879 citations

Medicine, Pharmacotherapy, Surgery +5

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · The Lancet · 2012 · 784 citations

Medicine, Neurology, Oncology +10

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Jacqueline A. French, John A. Lawson, Hiroko Ikeda et al. · The Lancet · 2016 · 747 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

Hope Northrup, Mary E. Aronow, E. Martina Bebin et al. · Pediatric Neurology · 2021 · 705 citations · Full text

Medicine, Genetics, Neurology +14

Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist

Petrus J. de Vries, Vicky Whittemore, Loren Leclezio et al. · Pediatric Neurology · 2014 · 382 citations

Medicine, Neurology, Psychiatry +5